JCR Pharmaceuticals Co Ltd 2022 Sustainability Report
The report describes the company's sustainability activities across rare diseases, the environment, society and corporate governance. It highlights climate scenario analysis based on TCFD recommendations and the establishment of Sustainability Advisory, Sustainability and Environmental Committees in July 2022. The consolidated financial highlights report FY2021 net sales of 51,082 million yen, reflecting strong product and licensing performance.
Company: JCR Pharmaceuticals Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2022
Type: Sustainability Report
Pages: 40
Back to company
JCR Pharmaceuticals Co Ltd
Sustainability Report
The report describes the company's sustainability activities across rare diseases, the environment, society and corporate governance. It highlights climate scenario analysis based on TCFD recommendations and the establishment of Sustainability Advisory, Sustainability and Environmental Committees in July 2022. The consolidated financial highlights report FY2021 net sales of 51,082 million yen, reflecting strong product and licensing performance.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2021
Published
Oct 1, 2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Water Consumption
Women on Board
Women in Management
Employees